Zacks Small Cap Research on MSN
ICU: Critical Care Innovation for AKI Patients; Initiating Coverage of SeaStar Medical Holding Corp.
ICU READ THE FULL ICU RESEARCH REPORT We are initiating coverage of SeaStar Medical Holding Corp. (NASDAQ:ICU) with a valuation of $12.00. SeaStar is a commercial-stage medical device company that is ...
SeaStar Medical’s 2026 milestones are built on the foundation of achievements from 2025 including: ...
SeaStar Medical Holding Corporation (NASDAQ:ICU) shares are trading higher on Thursday, on continued strength after the company received FDA Breakthrough Device Designation for its cell-directed ...
DENVER, April 08, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients ...
DENVER, Oct. 18, 2023 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a medical device company developing proprietary solutions to reduce the consequences of hyperinflammation ...
SeaStar Medical (NASDAQ:ICU) said it has received an Approvable Letter from the FDA for its Selective Cytopheretic Device Pediatric, or SCD-PED, for use in children with acute kidney injury and sepsis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback